Clinical Trial Update: Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating anticoagulation in patients with COVID-19–related ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Anticoagulation in COVID-19 ARDS | Phase 4 | Status: UNKNOWN